GET THE APP

Recent Trends in Cancer Research and Immuno-oncology
Journal of Cancer Research and Immuno-Oncology

Journal of Cancer Research and Immuno-Oncology
Open Access

ISSN: 2684-1266

Editorial - (2021)Volume 7, Issue 2

Recent Trends in Cancer Research and Immuno-oncology

Theodoros Michelakos*
 
*Correspondence: Theodoros Michelakos, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA, Email:

Author info »

Editorial Note

Journal of Cancer Research and Immuno-Oncology is a fastdeveloping open access journal in the field of cancer research. On behalf of the Board of the Journal of Cancer Research and Immuno-oncology and co-editors, I am glad to present the Volume 7, Issue 2 of the journal. The journal is established in 2015. Journal of Cancer Research and Immuno-Oncology is having International Standard Serial Number (ISSN) of 2684-1266. The journal is indexed and abstracted in refSeek, Hamdard University, EBSCO A-Z. Average download per article is increasing and all these are promising signs which shows the growth of the journal. Now we are in this stage only through the continuous support of Editorial Board Members and intellectual generosity of the readers and contributors (authors and reviewers).

This journal maintains good frequency of articles which are of good quality and always aims to flourish and maintain the standards in cancer research and immuno-oncology. This journal is much more interested in publishing articles which cover latest discoveries in the field of cancer research. This journal always publishes quality articles which will be very useful for research scholars, health care professionals and readers.

Main aims and objectives of this journal is to publish more and more quality articles of research, review, short commentary, mini reviews, case reports etc. which will be very useful for the readers. We accept articles which meets the aims and objectives and which are within the scope of the journal. We would like to publish articles which cover trending topics and which cover topics related to cancer cells, stem cells, T-cells, Breast cancer, Lung cancer, colon cancer, leukemia, melanoma, sarcoma, carcinoma, ovarian cancer, Glioblastoma, mesothelioma, Gatrinoma, soft tissue sarcoma, merkel cell carcinoma, Ewing sarcoma and different cell therapies including adoptive cell therapy and adjuvant Immuno therapy, monoclonal antibodies and different therapies which are used to treat cancer, etc.

Journal of Cancer Research and Immuno-oncology has editorial tracking system which made the authors to submit manuscripts online and to track them easily. Authors can track the Manuscript flow easily through the credentials provided to them. Editorial board members of this journal are very active and play a key role during the review process. Editorial board members and reviewers of this journal are eminent professionals, professors and doctors etc. who are from the world wide, act as major part of the journal. We are very thankful to the Editorial board members and reviewers who made the peer review process easily and issue release on time. Issue release was done on time without any delay. The editorial team follows strict guidelines to avoid any potential bias and conflict of interest while reviewing manuscripts. Journal functions on principles of scientific excellence, publication ethics and transparency. This together made the Journal of Cancer Research and Immuno-oncology a truly powerful publication and successful.

We invite authors to publish more articles related to COVID-19, which is a global pandemic and trending topic and the effects of vaccine on the patients and their side effects. As corona virus is more fatal to cancer patients, the effect of vaccination on cancer patients is much more need to be studied. Hence we would like to publish more articles on this which will be useful for future research.

Journal of Cancer Research and Immuno-oncology became very successful with good number of quality articles only with the support of authors, Editorial board members, reviewers and readers. With the support of authors, Editorial board members, reviewers and readers Journal of Cancer Research and Immunooncology became very successful with good number of quality articles and will reach good heights with this continuous support. The objective of JCRIO is to publish up-to-date, high-quality and original research papers alongside relevant and insightful reviews which make the journal to reach good heights.

Author Info

Theodoros Michelakos*
 
Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
 

Citation: Michelakos T (2021) Recent Trends in Cancer Research and Immuno-oncology. J Cancer Res Immunooncol. 7:e107.

Received: 02-Mar-2021 Accepted: 16-Mar-2021 Published: 23-Mar-2021 , DOI: 10.35248/2684-1266.21.7.e107

Copyright: © 2021 Michelakos T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top